Guan Siyu, Tang Qizhu, Liu Wenwei, Zhu Rui, Li Bin
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, 430060, China; Department of Cardiology, Xiangyang Central Hospital, Hospital Affiliated to Hubei University of Arts and Science, Xiangyang, 441021, China.
Drug Dev Res. 2014 Dec;75(8):489-96. doi: 10.1002/ddr.21230. Epub 2014 Nov 28.
Preclinical Research The abnormal migration and proliferation of vascular smooth muscle cells (VSMCs) plays a pivotal role in the development of neointimal hyperplasia after vascular injury. Nobiletin, a citrus bioflavonoid, exhibits anti-inflammatory and anti-oxidative activities. The present study evalutaed whether nobiletin could inhibit platelet-derived growth factor (PDGF)-BB- stimulated VSMC proliferation and migration and decrease neointimal hyperplasia in a rat carotid artery injury model. Cultured VSMCs from rat thoracic aortas were treated with nobiletin before being stimulated with 20 ng/ml PDGF-BB, and rats were subjected to carotid artery injury. Nobiletin inhibited PDGF-BB-induced VSMC proliferation and migration, attenuated reactive oxygen species (ROS) production and reduced phosphorylation of ERK1/2 and the expression of nuclear NF-κB p65 in PDGF-BB-stimulated VSMCs. Nobiletin decreased the intima area and the ratio of neointima to media in balloon-injured rat carotid arteries. Serum levels of TNF-α and IL-6 in nobiletin-treated rats were decreased. These results indicated that nobiletin could be a potential protective agent for the prevention and treatment of restenosis after angioplasty.
Atherosclerosis. 2012-7-24
J Cardiovasc Pharmacol Ther. 2013-1-15
Front Cell Dev Biol. 2023-8-11
Am J Physiol Gastrointest Liver Physiol. 2022-10-1
Tissue Eng Regen Med. 2022-8
Int J Mol Sci. 2020-1-4
Evid Based Complement Alternat Med. 2018-10-11
Mol Cell Endocrinol. 2018-4-20
Evid Based Complement Alternat Med. 2016